Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
NCT Number: NCT02989246
This pilot study tests the feasibility of using a computerized ventilator management protocol seeking to encourage lung protective ventilation during the acute phase of ventilation, and esophageal manometry based titration of ventilator settings during the weaning phase of ventilation, for children with acute respiratory failure. The investigators hypothesize that such an approach will reduce time on mechanical ventilation, largely by preserving diaphragm muscle function.
Looking for future studies?
Notify Me37 week–18 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90027, United States
Objectives: This pilot study will help refine a computer based ventilator management protocol which will be used in both acute and weaning phases of ventilation for children with acute respiratory failure. The acute phase protocol is an adaptation of the Acute Respiratory Distress Syndrome Network protocol for pediatrics, and the weaning phase involves an esophageal manometry guided weaning protocol based on effort of breathing. The investigators seek to test the safety and feasibility of the protocol recommendations and the software system , and help determine the potential effect size of the intervention to determine feasibility of a randomized controlled trial. They also seek to determine the feasibility and reproducibility of serial diaphragm ultrasound measurements on mechanically ventilated children.
Study Population: All children intubated and mechanically ventilated in the Children's Hospital Los Angeles Pediatric ICU with an anticipated length of intubation > 48 hours will be eligible, with some exclusion criteria based on ability to perform the measurements.
Study methodology: After consent, an esophageal catheter will be placed. A software management tool for ventilator management will be placed at the bedside for each enrolled patient, and recommendations regarding changing ventilator support will be provided to the clinicians every several hours during both acute and weaning phases. When ventilator support is below a threshold, recommendations will be made to perform spontaneous breathing trials. The clinicians will ultimately decide whether to accept or reject the recommendations, and will evaluate the patient before each potential change to the ventilator. The acceptance or rejection of recommendations will be tracked, and used to refine the intervention. Daily diaphragm ultrasound measurements will also be obtained to monitor diaphragm thickness and contractile activity.
Follow up: Clinical outcomes will be followed while in the ICU including re-intubation, medications administered, and ICU length of stay. No follow up after ICU discharge is planned.
Analysis plans: Data will be used to refine the intervention, test the acceptability of protocol recommendations to bedside providers, and determine sample size estimates for a follow up randomized controlled trial. These analyses will be descriptive. A pilot of 40 patients is anticipated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Open loop ventilator management by a computer based protocol
Esophageal manometry measurements of patient effort of breathing will be used to guide the protocol recommendations
Time frame: With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days)
The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted
Children's Hospital Los Angeles
Other
Effort of Breathing Guided Ventilator Management for Children Using Pressure Rate Product: a Pilot Study
Acronym: EOBvent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05759013
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Long Beach, California, United States
View Trial DetailsNCT04841746
COVID-19, Coronaviridae Infections
Saint-Genis-Laval, France
View Trial DetailsNCT05161962
Infections, Lung Diseases
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT03497559
Agnosia, Analgesia
Edmonton, Alberta, Canada
View Trial Details